
The 31st Society for Neuro-Oncology Annual Meeting and Education Day will feature multiple Independent Supported Symposia (ISS) Sessions. Morning, lunchtime and evening sessions will be offered. Below is a list of the confirmed ISS sessions
Independent Supported Session
Location: Liberty Ballroom, Philadelphia Marriott Downtown
More information coming soon.
Supported by SpringWorks Therapeutics
Independent Supported Session
Location: Independence Ballroom, Philadelphia Marriott Downtown
More information coming soon.
Supported by Decera Clinical
Grant Supported by Daiichi Sankyo & Astrazenaca
Independent Supported Session
Location: Room 108AB , Pennsylvania Convention Center
More information coming soon.
Supported by Decera Clinical
Grant Supported by Daiichi Sankyo & Astrazenaca
Independent Supported Session
Location: Room 115C, Pennsylvania Convention Center
More information coming soon.
Supported by Alexion Pharmaceuticals Inc.
Independent Supported Session
Location: Michael A. Nutter Theatre, Pennsylvania Convention Center
More information coming soon.
Supported by Day One Biopharmaceuticals.
Independent Supported Session
Location: Room 108AB, Pennsylvania Convention Center
More information coming soon.
Supported by Medscape.
Grant Supported by Servier.
Independent Supported Session
Location: Grand Ballroom Salon 1&2, The Notary Hotel
More information coming soon.
Supported by Novocure.
Implementing Systemic Therapy in H3 K27-Altered DMG: Practical Strategies to Optimize Post-Radiation Care
Location: Independence Ballroom, Philadelphia Marriott Downtown
Registration: Click here.
Speakers:
Stephen Bagley, MD
Carl Koschmann, MD
Karen Wright, MD
Supported by Decera Clinical.
Grant Supported by Jazz Pharmaceuticals.
Independent Supported Session
Location: Room 115AB, Pennsylvania Convention Center
More information coming soon.
Supported by BrainSpec.
Optimizing NF1 Tumor Management Across the Lifespan: Integrating Pain and Quality-of-Life Assessment into MEK Inhibitor and Surgical Decision-Making
Location: Room 108AB, Pennsylvania Convention Center
The education will address multidisciplinary management of neurofibromatosis type 1-associated plexiform neurofibromas across pediatric and adult care settings. Faculty will examine how patient-reported pain, functional impact, and quality of life should influence decisions to observe, initiate treatment, or escalate care. The program will also explore how MEK inhibitor therapy can be integrated with surgery, including patient selection and potential neoadjuvant, adjuvant, and salvage approaches. Finally, learners will review practical strategies for anticipating, monitoring, and managing MEK inhibitor-related toxicities while maintaining treatment intensity and avoiding unnecessary discontinuation.
Supported by CEConcepts.
Grant Supported by Alexion Pharmaceuticals Inc. & SpringWorks Therapeutics.
Independent Supported Session
Location: Michael A Nutter Theatre, Pennsylvania Convention Center
More information coming soon.
Supported by Day One Biopharmaceuticals.
Independent Supported Session
Location: Room 115C, Pennsylvania Convention Center
More information coming soon.
Supported by Oxford Nanopore Technologies Inc.
Independent Supported Session
Location: Liberty Ballroom, Philadelphia Marriott Downtown
More information coming soon.
Supported by Telix Pharmaceuticals.
Independent Supported Session
Location: Room 108AB, Pennsylvania Convention Center
More information coming soon.
Supported by Cerenome (Formerly Plus Therapeutics).
Independent Supported Session
Location: Michael A. Nutter Theatre, Pennsylvania Convention Center
More information coming soon.
Supported by Belay Diagnostics.
Independent Supported Session
Location: Liberty Ballroom ABC, Philadelphia Marriott Downtown
More information coming soon.
Supported by Jazz Pharmaceuticals.
Independent Supported Session
Location: Juniper Ballroom, The Notary Hotel
More information coming soon.
Supported by Servier Pharmaceuticals.